Dr. Petros Grivas, MD of Cleveland Clinic discusses The association of D4, 3-keto-abi (D4A) and response to abiraterone in castration-resistant prostate cancer (CRPC) from ASCO GU 2016.
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content